Project documents | Apalutamide for treating non-metastatic, hormone-relapsed prostate cancer [ID1174] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 235 KB)

Published:

29 November 2018
Equality Impact Assessment (Guidance development) (PDF 174 KB)

Published:

29 November 2018
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 372 KB)

Published:

29 November 2018
Final stakeholder list (PDF 263 KB)

Published:

29 November 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 327 KB)

Published:

15 August 2018
Draft matrix post referral (PDF 264 KB)

Published:

15 August 2018